Avanos Medical AVNS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's EPS (diluted)?
- Avanos Medical (AVNS) reported EPS (diluted) of $0.11 in Q1 2026.
- How has Avanos Medical's EPS (diluted) changed year-over-year?
- Avanos Medical's EPS (diluted) decreased by 21.4% year-over-year, from $0.14 to $0.11.
- What is the long-term trend for Avanos Medical's EPS (diluted)?
- Over 3 years (2021 to 2025), Avanos Medical's EPS (diluted) has grown at a 129.4% compound annual growth rate (CAGR), from $0.13 to -$1.57.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.